Compare RDHL & ELAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RDHL | ELAB |
|---|---|---|
| Founded | 2009 | 2020 |
| Country | Israel | United States |
| Employees | N/A | 34 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8M | 6.4M |
| IPO Year | 2012 | N/A |
| Metric | RDHL | ELAB |
|---|---|---|
| Price | $0.80 | $3.47 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 22.5K | ★ 13.3M |
| Earning Date | 05-01-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $381.91 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.71 | $0.66 |
| 52 Week High | $3.31 | $15.00 |
| Indicator | RDHL | ELAB |
|---|---|---|
| Relative Strength Index (RSI) | 41.73 | 47.81 |
| Support Level | $0.79 | $1.68 |
| Resistance Level | $0.89 | $4.61 |
| Average True Range (ATR) | 0.05 | 1.63 |
| MACD | 0.01 | -0.28 |
| Stochastic Oscillator | 51.31 | 1.49 |
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.
PMGC Holdings Inc IS advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.